Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rang in Aktien #2093
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aktienkurs
$141.47
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$9.81B
Veränderung (1 Tag)
0.26%
Veränderung (1 Jahr)
-56.72%
Land
US
Handel Insulet Corp. (PODD)

Kategorie

Healthcare
Aktien-Split-Historie für Insulet Corp. (PODD)
Die Aktie Insulet Corp. (Symbol: PODD) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 20, 2026 statt.
Eine PODD-Aktie, die vor dem Oct 20, 2026 gekauft wurde, entspricht heute 0 PODD-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE